9-Aminoacridine hydrochloride
Common Name: |
9-Aminoacridine hydrochloride |
IUPAC Name: |
acridin-9-amine;hydrochloride |
Molecular Formula: |
C13H10N2 |
SMILES: |
C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)N.Cl |
Inchi: |
1S/C13H10N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1-8H,(H2,14,15);1H |
Inchi Key: |
FTGPOQQGJVJDCT-UHFFFAOYSA-N |
Cas No: |
134-50-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
230.69 |
Mass (g/mol) |
230.061 |
Molar Refractivity |
70.62 |
Net Charge |
1 |
HBD |
1 |
HBA |
1 |
Rt Bonds |
0 |
Rings |
3 |
TPSA |
38.91 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
14 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.00 |
LogP |
2.97 |
iLOGP |
0.00 |
XLOGP3 |
3.54 |
WLOGP |
3.78 |
MLOGP |
2.67 |
ESOL Log S |
-4.15 |
ESOL Solubility (mg/ml) |
0.016 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-4.04 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-5.02 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-5.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.658 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
1 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
2.616 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
1 |